Company Filing History:
Years Active: 2005
Title: The Innovations of Matthew J Kostura
Introduction
Matthew J Kostura is an accomplished inventor based in Perkasie, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of radioligands and binding assays. His work is instrumental in advancing medical research and potential treatments.
Latest Patents
Kostura holds a patent for a radioligand compound, specifically [S]-radiolabeled (+)-N-[1'-(6-cyano-1,2,3,4-tetrahydro-2(R)-naphthalenyl)-3,4-dihydro-4(R)-hydoxyspiro[2H-1-benzopyran-2,4′-piperidin]-6-yl]methanesulfonamide. This invention includes a method for identifying compounds that bind to the I channel, which may exhibit antiarrhythmic activity. His innovative approach has the potential to impact the treatment of heart conditions.
Career Highlights
Kostura is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Kostura has worked alongside notable colleagues such as John W Butcher and David A Claremon. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Matthew J Kostura's contributions to the field of pharmaceuticals through his patent and work at Merck & Company, Inc. highlight his dedication to innovation and research. His efforts are paving the way for future advancements in medical treatments.